TESTPOINT BY GEMINA Trademark

Trademark Overview


On Wednesday, September 8, 2021, a trademark application was filed for TESTPOINT BY GEMINA with the United States Patent and Trademark Office. The USPTO has given the TESTPOINT BY GEMINA trademark a serial number of 97017874. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, May 3, 2024. This trademark is owned by Gemina Laboratories Ltd.. The TESTPOINT BY GEMINA trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

Downloadable computer software for use in the workplace to record, monitor, track and report COVID-19, coronavirus related risks, viruses, pathogens, and biomarkers

Providing temporary use of online non-downloadable software for use in the workplace to record, monitor, track, and report COVID-19, corona virus related risks, viruses, pathogens, and biomarkers; Platform as a service (PAAS) featuring computer software platforms for use in the workplace to record, monitor, track, and report COVID-19 and other coronavirus related risks, or the presence of other virus, pathogens, and biomarkers
testpoint by gemina

General Information


Serial Number97017874
Word MarkTESTPOINT BY GEMINA
Filing DateWednesday, September 8, 2021
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, May 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDownloadable computer software for use in the workplace to record, monitor, track and report COVID-19, coronavirus related risks, viruses, pathogens, and biomarkers
Translation of Words in MarkThe English translation of GEMINA in the mark is twins.
Goods and ServicesProviding temporary use of online non-downloadable software for use in the workplace to record, monitor, track, and report COVID-19, corona virus related risks, viruses, pathogens, and biomarkers; Platform as a service (PAAS) featuring computer software platforms for use in the workplace to record, monitor, track, and report COVID-19 and other coronavirus related risks, or the presence of other virus, pathogens, and biomarkers

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateMonday, October 18, 2021
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 18, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGemina Laboratories Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressVancouver, B.C. V6S2L9
CA

Trademark Events


Event DateEvent Description
Monday, October 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 11, 2021NEW APPLICATION ENTERED
Wednesday, March 2, 2022ASSIGNED TO EXAMINER
Saturday, March 12, 2022NON-FINAL ACTION WRITTEN
Saturday, March 12, 2022NON-FINAL ACTION E-MAILED
Saturday, March 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 1, 2022SUSPENSION LETTER WRITTEN
Monday, September 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 1, 2022LETTER OF SUSPENSION E-MAILED
Thursday, December 1, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, October 15, 2023SUSPENSION INQUIRY WRITTEN
Thursday, June 15, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sunday, October 15, 2023INQUIRY TO SUSPENSION E-MAILED
Sunday, October 15, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, December 12, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, May 2, 2024ASSIGNED TO LIE
Thursday, May 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 3, 2024SUSPENSION LETTER WRITTEN
Friday, May 3, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 3, 2024LETTER OF SUSPENSION E-MAILED